Tropical Health Systems’
platform technology is designed specifically to address the requirements of
point-of-care and critical-care settings, and to increase access to accurate
diagnosis of life-threatening diseases and monitoring of chronically ill patients.
pScreen™
is a patent-protected biosensor platform. It is a disposable, highly sensitive,
immunoassay for the detection and quantification of proteins/biomarkers at the
point-of-care. It provides accurate and quantitative results, in a matter of 15
minutes or less, on drop-size body fluid, such as blood, saliva, and urine.
pScreen™
brings complex and expensive in-vitro diagnostic tests out of the laboratory
into the point-of-care settings, including doctor’s offices, patient’s bedside,
homes, and low-resources settings. It provides accurate results that
compare for sensitivity and specificity to ELISA and other lab-based
immunoassays, while remaining low-cost, robust, easy to use, portable and
entirely disposable.
Unlike any other
point-of-care or laboratory-based immunoassays, pScreen™ does not
require electrical power, battery or supporting hand-held devices. Hence, pScreen™
is entirely disposable and low cost. This feature makes pScreen™
uniquely positioned to become the Point-of-Care diagnostic test of choice for
millions of people and healthcare practitioners.
Disclaimer: Tropical
Health Systems makes no representation that materials at this Site are
appropriate or available for use in or outside the United States. The contents
of this site are copyrighted unless otherwise noted.